The Centers for Medicare & Medicaid Services will reweight the cost performance category for the Merit-based Incentive Payment System from 15% to 0% for the 2020 performance period — which affects 2022 payments — due to the impact of the COVID-19 public health emergency, and redistribute the 15% prescribed weight to another performance category or categories. 

“Our analysis of the underlying data for the 2020 performance year, in comparison to prior years’ data, shows that the volume of data available to calculate the scores for the cost measures has significantly decreased overall,” CMS said. “As a result, we do not believe we can reliably calculate scores for the cost measures that would adequately capture and reflect the performance of MIPS eligible clinicians.”

Because the cost performance category relies on administrative claims data, clinicians do not need to take any action, CMS said. For more on the Quality Payment Program, visit the QPP website
 

Related News Articles

Blog
A recent report from RAND misses the mark on solutions to the cost of health care and draws its conclusions from the same recycled and incomplete studies.…
Headline
Due to the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will apply an automatic extreme and uncontrollable circumstances…
Headline
The Centers for Medicare & Medicaid Services has extended to Feb. 1 at 8 p.m. ET the deadline for clinicians participating in the Merit-based Incentive…
Headline
Ninety-eight percent of eligible clinicians who reported data in the 2019 Quality Payment Program through the Merit-based Incentive Payment System track will…
Headline
Clinicians who participated in the Merit-based Incentive Payment System in 2019 have until Oct. 5 at 8 p.m. ET to review their final score and payment…
Blog
The RAND Corporation has released the third edition of its hospital price transparency study. The AHA previously highlighted our extensive concerns with the…